Articles related to NEURODEGENERATIVE DISEASES

Understanding the potential impact of household chemical exposures on ALS risk underscores the importance of environmental assessments in neurological care.

The latest advancements in MRI technology are offering unparalleled insights into the brain’s anatomy, promising to enhance our diagnostic and therapeutic strategies for a range of neurological and psychiatric conditions.

This study unveils a blood-based biomarker test capable of identifying individuals at risk of Parkinson’s Disease and related dementias with remarkable precision, promising a new era in the proactive management of neurodegenerative disorders.

A groundbreaking study in The Lancet Neurology reports that 94% of patients with posterior cortical atrophy also have Alzheimer’s disease pathology, stressing the need for heightened awareness among clinicians for earlier diagnosis and intervention.

This study uncovers a critical connection between contaminated pituitary-derived hormone treatments and the subsequent development of early-onset Alzheimer’s disease, highlighting the necessity for stringent safety protocols in medical treatments.

New research highlights the potential link between viral infections, such as pneumonia post-flu and viral encephalitis, and an increased risk of neurodegenerative diseases. This underscores the importance of vaccination in potentially reducing these risks.